Intended for healthcare professionals

Rapid response to:

Editorials

High cost of new drugs

BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4136 (Published 27 July 2016) Cite this as: BMJ 2016;354:i4136

Rapid Response:

Re: High cost of new drugs

NEED PRICE CONTROL

Life saving and disease specific newer agents like drugs for hepatitis C viral infection must be brought under price control and the Government should also give subsidies to cut down the cost of the newer drugs.

Every one's life is precious. So the drug companies with patents for the newer molecules must also cooperate in this matter to give these drugs at an affordable price.

This type of policy decision may also help patients in both developing and under developed countries, as well as patients in well developed Nations.

Competing interests: No competing interests

28 July 2016
M A Aleem
Neurologist
A M Hakkim
ABC Hospital and Apollo Hospital
Annamalainagar Trichy 620018 Tamilnadu India. Apollo Hospital chennai Bypass Trichy 620010 and Apollo clinic 6th cross Thillainagar Trichy 620018 Tamilnadu India